Updated:
Harvest One Cannabis Inc.
Harvest One Cannabis, founded 2014 in Vancouver, pivoted from cultivation to branded CPG before becoming HAVN Life Sciences.
Harvest One Cannabis Inc.
Harvest One Cannabis was founded in 2014 by Grant Froese and other co-founders, initially positioning as a licensed cannabis producer under Canada's legalized regime. The company listed on the TSX Venture Exchange in 2018, raising capital to build cultivation and extraction capacity in British Columbia and Ontario. The firm's strategy evolved post-legalization, shifting from commodity-driven cultivation toward branded consumer goods, including its Dream Water sleep-aid line and CBD-infused wellness products. Harvest One's portfolio spanned licensed producer status, extraction partnerships, and retail-facing brands in the Canadian and international CPG markets. By 2020, the company faced headwinds including regulatory delays, capital constraints, and market oversupply. It consolidated facilities and focused on cost reduction. In 2022, Harvest One changed its name to HAVN Life Sciences Inc., signaling a pivot to psychedelics and wellness before ultimately ceasing operations. Harvest One's structural differentiator was its attempt to bridge the gap between regulated cannabis production and mainstream CPG distribution — a hybrid model rarely executed successfully in the sector. The company's governance as a public entity under TSX rules provided transparency unusual among private cannabis firms.
General information
Firm type
other
Year founded
2014
AUM
Undisclosed
Location
Region
North America
Country
Canada
City
Vancouver
Corporate office
Vancouver, British Columbia, Canada
Additional offices
Sudbury, Canada
Principals
Grant Froese
CEO
David B. M. S. MacNaughton
Director
Sector focus
Frequently asked questions
Who ran investment decisions at Harvest One?
CEO Grant Froese led the firm's strategic direction from founding through its pivot to HAVN Life Sciences. The board included directors with backgrounds in mining, finance, and cannabis regulation.
What was Harvest One's business model?
Harvest One operated as a licensed Canadian cannabis producer that also developed branded consumer wellness products, including Dream Water and CBD formulations. It held cultivation, extraction, and distribution licenses.
Why did Harvest One change its name to HAVN Life Sciences?
In 2022, Harvest One pivoted toward psychedelics and wellness, reflecting broader industry trends and capital market interest. The rebranding aimed to align with new regulatory pathways and investor demand.
Did Harvest One serve as a family office or investment vehicle?
No. Harvest One was a publicly traded cannabis firm listed on the TSX Venture Exchange. Its structure was corporate, not a family office.
What investment stages or sectors did Harvest One target?
Harvest One focused on the regulated cannabis and CPG wellness sectors. It participated in direct cultivation, product development, and acquisitions of brands like Dream Water. It did not operate as a fund or allocate capital externally.
How is Harvest One distinct from other cannabis companies?
Harvest One attempted to combine licensed production with mainstream CPG distribution — a model few cannabis firms successfully executed. Its public listing provided transparency but also exposed it to market volatility.
What are Harvest One's known operational metrics?
Public financial data from its TSX filings show revenue growth from 2018 to 2020, followed by declining sales and eventual restructuring. Specific AUM or deployment figures are not publicly disclosed.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: